Cellectricon

Biotechnology ResearchVästra Götaland, Sweden11-50 Employees

Cellectricon, based in Mölndal, Västra Götaland, Sweden, specializes in neuroscience drug discovery by delivering highly customized in vitro neurobiology services with a commitment to scientific excellence and quality. The company operates a broad platform that enables the creation of complex disease models and assays for functional and morphological screening, combining drug-discovery know-how with disease-area expertise. Its service modules address Neuroinflammation, Peripheral Neuropathies, Neurodegeneration, and Neuroplasticity, supporting early target and lead-discovery programs. The organization aims to accelerate early R&D, shorten time to decision, and provide novel disease biology insights that help identify targets and lead compounds with potential to yield first-in-class medicines for its clients. In November 2025, Cellectricon integrated with CCRM Nordic AB to expand scalable manufacturing approaches for complex cell models used in early drug discovery and safety testing.

Sign up for free to view info

Email Format Employee directory